Barclays Suggests USIran Deal Progress May Broaden Global Equity Rally HLMN Q1 2026 Earnings EPS Misses Estimates as Company Navigates Soft Demand Environment Sarepta Therapeutics Maps 2026 Priorities from Strong Cash Position